Skip to content

A Clinical Trial for the Interventional Robotic System

A Multi-Center, Randomized, Non-Inferiority, Prospective and Parallel-Group Trial to Evaluate the Safety and Efficacy of the Interventional Robotic System for Cerebral Angiography

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05778214
Enrollment
142
Registered
2023-03-21
Start date
2023-02-28
Completion date
2024-12-31
Last updated
2023-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Angiography

Keywords

Cerebral Angiography, Interventional Surgical Robot

Brief summary

The goal of this multi-center clinical trial is to evaluate the efficacy and safety of the interventional robotic system for cerebral angiography, researchers will compare the ordinary angiography to assess the clinical success rate, operation time, radiation absorption, etc.

Interventions

DEVICEInterventional Robotic System

Cerebral angiography was performed by using the interventional robotic system

Sponsors

Changhai Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

1. Age ≥ 18 and ≤ 85 years; 2. Plan to undergo cerebral angiography; 3. Voluntarily participated in this trial and signed the informed consent form.

Exclusion criteria

1. Preoperative mRS score \>2; 2. Allergy or intolerance to iodine contrast media; 3. Allergy to interventional devices; 4. Severe cardiac, hepatic and renal insufficiency; 5. Active systemic infection; 6. Severe stenosis, occlusion or skin infection at the puncture site; 7. Subjects who are to undergo surgery at the same time as cerebral angiography; 8. Subjects with severe coagulation disorders, bleeding tendencies, or contraindications to anticoagulant drugs (e.g., heparin); 9. Subjects who are enrolled in clinical studies with other devices or drugs 3 months prior to screening; 10. Female subjects of childbearing age who are pregnant or breastfeeding; 11. Other subjects who, in the judgment of the investigator, are not suitable for participation in this trial.

Design outcomes

Primary

MeasureTime frameDescription
Clinical Success Rateat the end of surgeryAssessment of the clinical success rate of the surgical physician in completing cerebral angiography examination through the operation of experimental instruments or artificial means.

Secondary

MeasureTime frameDescription
Super-selective Catheterization Time for Target Vesselsat the end of surgeryCalculate and compare the average time taken to perform super-selective catheterization for each target vessel during each surgical procedure.
DSA Fluoroscopy Timeat the end of surgeryRecord and compare the duration of fluoroscopy during DSA for each surgical procedure.
Super-selective Technique Success Rateat the end of surgeryAssessing the technical success rate of the surgical physician in performing super-selective catheterization of cerebral vessels through the operation of experimental instruments or artificial means.
Primary Operator Radiation Absorbed Doseat the end of surgeryRecord and compare the absorbed dose of ionizing radiation received by the primary operator during each surgical procedure.
Instrument Performance Evaluationat the end of surgeryThe surgical physician fills out a form after the surgery to subjectively evaluate the performance of the experimental instruments during the angiographic examination procedure.
Surgical Timeat the end of surgeryRecord and compare the duration of each surgical procedure.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026